When you do a home test, bring the results to your next doctor’s appointment, who can help you evaluate the results so you ...

A jury in Atlanta federal court has sided with Teva Pharmaceuticals in the first trial testing claims the company failed to ...

I've been writing and editing stories for almost two decades that help people use technology and productivity techniques to ...

If you're in your 40s, you might think colon cancer is something to worry about decades from now. But alarming new research ...

The Global Gastrointestinal Diagnostics Market is poised for growth, driven by increasing demand for early detection due to aging populations and rising digestive disorders. Opportunities lie in ...

In the assessment of 12-month price targets, analysts unveil insights for Exact Sciences, presenting an average target of $91.88, a high estimate of $105.00, and a low estimate of $75.00. This upward ...

If it feels like everyone is getting the flu, you're not imagining it. This is shaping up to be another severe flu season. That's why it's important to take advantage of every tool we have to keep the ...

Abbott recently announced that it agreed to acquire Exact Sciences for approximately $21 billion to enter the fast-growing cancer diagnostic segment. Under the terms of the agreement, Abbott will ...

Good manners never go out of style, but they do occasionally need to be refreshed. In workplaces everywhere, that refresher couldn’t come sooner. In the decade since the previous edition of “Emily ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...